AGER and heart failure: The soluble form of RAGE (sRAGE) can be measured in the circulation and lower levels could serve as a biomarker for airflow obstruction [34], while levels seem to be elevated in patients with heart failure, indicating that interpretation of this biomarker in the context of cardiopulmonary interaction remains unclear [37].